Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

Diabetes

Volumn 54, Issue SUPPL. 2, 2005, Pages

  Palmer, Jerry P ^a,b,c   Hampe, Christiane S ^a   Chiu, Harvey ^a,b   Goel, Amit ^a,b   Brooks Worrell, Barbara M ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c Puget Sound Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED PROTEIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED PROTEIN A 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED PROTEIN A 5.1; PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LATENT AUTOIMMUNE DIABETES IN ADULTS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGE FACTORS; AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOGLOBULIN G; INSULIN RESISTANCE; REACTION TIME;

EID: 33644761984     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.suppl_2.S62     Document Type: Article

References (33)

1. Bottazzo G-F, Florin-Christensen A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279-1282, 1974
2. MacCuish AC, Irvine WJ, Barnes EW, Duncan LJP: Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet 2:1529-1531, 1974
3. Irvine WJ, Gray RS, McCallum CJ, Duncan LJP: Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents. Lancet 1:1025-1027, 1977
4. Chiu HK, Palmer JP: Autoimmune diabetes: more than just one flavor? J Endocrinol Invest 27:480-484, 2004
5. Naik RG, Palmer JP: Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord 4:233-241, 2003
6. Juneja R, Palmer JP: Type 1 1/2 diabetes: myth or reality? Autoimmunity 29:65-83, 1999
7. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M: A comparison of childhood and adult type I diabetes mellitus. N Engl J Med 320:881-886, 1989
8. Lorenzen T, Pociot F, Hougaard P, Nerup J: Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 37:321-327, 1994
9. Palmer JP, Hirsch IB: What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-oneset, and type 1 diabetes. Diabetes Care 26:536-538, 2003
10. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
11. Kahn SE: The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047-4058, 2001
12. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA: Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692-1698, 2002
13. Verge CF, Gianani R, Kawasaki E, Yu LP, Pietropaolo F, Chase HP, Eisenbarth GS: Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun 9:379-383, 1996
14. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
15. Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS, the Diabetes Prevention Trial-Type 1 Study Group: Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metabol 88:103-108, 2003
16. Seissler J, DeSonnaville JJJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA: Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 41:891-897, 1998
17. Falorni A, Gambelunghe G, Forini F, Kassi G, Cosentino A, Candeloro P, Bolli GB, Brunetti P, Calcinaro F: Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab 85:309-613, 2000
18. Hampe CS, Kockum I, Landin-Olsson M, Torn C, Örtqvist E, Persson B, Rolandsson O, Palmer JP, Lernmark Å: GAD65 antibody epitope patterns of type 1.5 diabetes patients are consistent with slow onset autoimmune diabetes. Diabetes Care 25:1481-1482, 2002
19. Padoa CJ, Banga JP, Madec A-M, Ziegler M, Schlosser M, Örtqvist E, Kockum I, Palmer JP, Rolandsson O, Binder KA, Foote J, Luo D, Hampe CS: Recombinant Fab of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs. Diabetes 52:2689-2695, 2003
20. Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, Lernmark Å: Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 88:4768-4775, 2003
21. Hillman M, Törn C, Thorgeirsson H, Landin-Olsson M: IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes. Diabetologia 47:1984-1989, 2004
22. th Annual Conference of the Federation of Clinical Immunology Societies, Montreal, Canada, July 18-23, 2004
23. Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP: Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J Immunol 157:5668-5674, 1996
24. Brooks-Worrell BM, Juneja R, Minokadeh A, Greenbaum CJ, Palmer JP: Cellular immune responses to human islet protein in antibody positive type 2 diabetic patients. Diabetes 48:983-988, 1999
25. Brooks-Worrell B, Gersuk VH, Greenbaum C, Palmer JP: Intermolecular antigen spreading occurs during the pre-clinical period of human type 1 diabetes. J Immunol 166:5265-5270, 2001
26. Behme MT, Dupré J, Harris SB, Hramiak IM, Mahon JL: Insulin resistance in latent autoimmune diabetes of adulthood. Ann N Y Acad Sci 1005:374-377, 2003
27. Zimnan B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI: Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53:3193-3200, 2004
28. Sanjeevi CB, Gambelunghe G, Falorni A, Shtauvere-Brameus A, Kanungo A: Genetics of latent autoimmune diabetes in adults. Ann N Y Acad Sci 958:107-111, 2002
29. Groop L, Miettinen A, Groop P-H, Meri S, Koskimies S, Bottazzo GF: Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type II diabetes. Diabetes 37:99-103, 1988
30. Cosentino A, Gambelunghe G, Tortoioli C, Falorni A: CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann N Y Acad Sci 958:337-340, 2002
31. Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD: Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults. Mol Diagn 8:43-49, 2004
32. Törn C, Gupta M, Zake LN, Sanjeevi CB, Landin-Olsson M: Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults. Hum Immunol 64:902-909, 2003
33. Vatay Á, Rajczy K, Pozsonyi É, Hosszúfalusi N, Prohászka Z, Füst G, Karádi I, Szalai C, Grósz A, Bártfai Z, Pánczél P: Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunol Lett 84:109-115, 2002